首页 | 本学科首页   官方微博 | 高级检索  
检索        

mTOR信号通路调控糖尿病肾病肾小球肥大的机制及中药的干预作用
引用本文:杨晶晶,黄燕如,万毅刚,沈山梅,毛志敏,吴薇,姚建.mTOR信号通路调控糖尿病肾病肾小球肥大的机制及中药的干预作用[J].中国中药杂志,2015,40(16):3125-3131.
作者姓名:杨晶晶  黄燕如  万毅刚  沈山梅  毛志敏  吴薇  姚建
作者单位:南京中医药大学 中西医结合鼓楼临床医学院, 江苏 南京 210029,Department of Molecular, Signaling University of Yamanashi, Japan Yamanashi 409-3898,南京大学 医学院 附属鼓楼医院 中医科, 江苏 南京 210008,南京大学 医学院 附属鼓楼医院 内分泌科, 江苏 南京 210008,南京中医药大学 中西医结合鼓楼临床医学院, 江苏 南京 210029,南京中医药大学 中西医结合鼓楼临床医学院, 江苏 南京 210029,Department of Molecular, Signaling University of Yamanashi, Japan Yamanashi 409-3898
基金项目:国家自然科学基金面上项目(81374030);南京市卫生青年人才培养工程项目
摘    要:肾小球肥大(glomerular hypertrophy)是糖尿病肾病(diabetic nephropathy,DN)早期阶段最主要的病理特征,其调控机制与哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)信号通路活性密切相关。mTOR包括mTORC1和mTORC2,其中,mTORC1上游信号通路是磷脂酰肌醇3激酶(phosphatidylinositol-3-kinase,PI3K)/丝氨酸-苏氨酸激酶(serine-threonine kinase,Akt)/5-单磷酸腺苷活性蛋白激酶(adenosine monophosphate activated protein kinase,AMPK),其代表性的下游信号分子是4E结合蛋白(4E-binding proteins,4EBP)和70 kD核糖体S6激酶(phosphoprotein 70 S6Kinase,p70S6K)。一些中药提取物可以在体外通过干预PI3K/Akt/mTOR信号通路关键上、下游信号分子的表达而改善细胞增殖。对于肾小球系膜细胞和足细胞,mTOR通过调节细胞周期、能量代谢以及相关的基质蛋白合成等多种途径对肾小球固有细胞发挥着重要的调控作用。对于DN动物模型,mTOR抑制剂——雷帕霉素可抑制肾小球固有细胞肥大、增殖以及相应的肾小球基底膜增厚和系膜基质沉积。一些中药提取物在体内外可以通过干预DN肾组织或肾脏固有细胞mTOR信号通路的活性而减轻相应的肾小球病变。

关 键 词:糖尿病肾病  中药  肾小球肥大  mTOR信号通路
收稿时间:4/5/2015 12:00:00 AM

Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine
YANG Jing-jing,HUANG Yan-ru,WAN Yi-gang,SHEN Shan-mei,MAO Zhi-min,WU Wei and YAO Jian.Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine[J].China Journal of Chinese Materia Medica,2015,40(16):3125-3131.
Authors:YANG Jing-jing  HUANG Yan-ru  WAN Yi-gang  SHEN Shan-mei  MAO Zhi-min  WU Wei and YAO Jian
Institution:Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China,Department of Molecular Signaling University of Yamanashi, Yamanashi 409-3898, Japan,Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Department of Traditional Chinese Medicine, Nanjing 210008, China,Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Department of endocrinology, Nanjing 210008, China,Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China,Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing 210029, China and Department of Molecular Signaling University of Yamanashi, Yamanashi 409-3898, Japan
Abstract:Glomerular hypertrophy is the main pathological characteristic in the early stage of diabetic nephropathy(DN), and its regulatory mechanism is closely related to mammalian target of rapamycin(mTOR) signaling pathway activity. mTOR includes mTOR complex 1(mTORC1)and mTOR complex 2(mTORC2), in which, the upstream pathway of mTORC1 is phosphatidylinositol-3-kinase(PI3K)/serine-threonine kinase(Akt)/adenosine monophosphate activated protein kinase(AMPK), and the representative signaling molecules in the downstream pathway of mTORC1 are 4E-binding proteins(4EBP)and phosphoprotein 70 S6Kinase(p70S6K). Some Chinese herbal extracts could improve cell proliferation via intervening the expressions of the key molecules in the upstream or downstream of PI3K/Akt/mTOR signaling pathway in vivo. As for glomerular mesangial cells(MC)and podocyte, mTOR plays an important role in regulating glomerular inherent cells, including adjusting cell cycle, energy metabolism and matrix protein synthesis. Rapamycin, the inhibitor of mTOR, could suppress glomerular inherent cell hypertrophy, cell proliferation, glomerular basement membrane(GBM)thickening and mesangial matrix deposition in model rats with DN. Some Chinese herbal extracts could alleviate glomerular lesions by intervening mTOR signaling pathway activity in renal tissue of DN animal models or in renal inherent cells in vivo and in vitro.
Keywords:diabetic nephropathy  Chinese herbal medicine  glomerular hypertrophy  mTOR signaling pathway
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号